StockData
Palomino Laboratories Inc. logo

Palomino Laboratories Inc. (PALX) stock

PALXOTCSemiconductors & Related DevicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$14.00−0.32 (-2.23%)

Close on Oct 15, 2026Market cap $305.46MP/E –Yield –

Palomino Laboratories operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Palomino Laboratories's operating income for the twelve months ending Jun 30, 2026 was -$4.96M. For fiscal 2025 it was -$2.70M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.70M–
FY2024Dec 31, 2024-$6.12K–
FY2023Dec 31, 2023-$83.94K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.37M–
Q1 FY2026Mar 31, 2026-$1.24M–
Q4 FY2025Dec 31, 2025-$742.64K–
Q3 FY2025Sep 30, 2025-$1.60M–
Q2 FY2025Jun 30, 2025-$337.45K–
Q1 FY2025Mar 31, 2025-$17.83K–
Q4 FY2024Dec 31, 2024-$4.01K–
Q3 FY2024Sep 30, 2024-$1.23K–
Q2 FY2024Jun 30, 2024-$31.79K–
Q1 FY2024Mar 31, 2024-$51.30K–
Q4 FY2023Dec 31, 2023-$32.57K–
Q3 FY2023Sep 30, 2023-$42.86K–
Q3 FY2022Sep 30, 2022-$4.25K–

More Palomino Laboratories figures

See a number that looks wrong?